AIT Worldwide Logistics debuts new global headquarters in Chicago suburbs
14.8.2023 18:03:00 EEST | Business Wire | Press release
Corporate teammates for supply chain solutions leader AIT Worldwide Logistics recently moved into a new global headquarters at 2 Pierce Place in Itasca, Illinois. Previously, AIT’s shared services teams were based out of multiple Itasca facilities, including 701 Rohlwing Rd., a single-story building and warehouse that had been shared with the company’s Chicago station since 1997.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230814443050/en/
AIT’s new global headquarters occupies multiple floors of the iconic 25-story suburban tower at 2 Pierce Place in Itasca, Illinois. (Photo: Business Wire)
According to AIT’s Chairman and CEO, Vaughn Moore, the move was spurred by the organization’s exponential growth and emergence as a global logistics powerhouse.
“After more than 40 years in business, and immense expansion to more than 110 locations across Asia, Europe and North America, we’re fortifying our roots in the Chicago area,” Moore said. “This modern, highly visible location is a true manifestation of our global brand, and it provides our corporate staff with both the space and resources they need to best support our customers and teammates around the world.”
Moore added that the new location is a major investment in AIT teammates’ on-site work experience.
“Working together in this state-of-the-art office space allows us to be much more collaborative, enabling faster, real-time reactions,” he said. “2 Pierce Place also provides the additional space we need to accommodate the future growth of our shared services teams.”
AIT’s global headquarters occupies multiple floors of the iconic 25-story suburban tower. Standing at 395 feet, it is the second-tallest building in Illinois outside the Chicago city limits. From its modern lobby to the tenant lounge, game room and outdoor patio, 2 Pierce Place offers popular on-site amenities, including a fitness center, walking trail, a full-service deli serving breakfast and lunch, grab-and-go dining options, and on-site catering services.
Team members from accounting, claims, finance, global business systems, global compliance, human resources, imaging, information technology, legal and marketing are stationed on newly remodeled high-rise floors with conveniences including a private game room, coffee bars, sit-stand workstations, and multiple conference rooms equipped with state-of-the-art audio-visual capabilities.
In the coming months, the remaining Chicago area AIT teams in Itasca and Wood Dale (including dedicated food logistics and life sciences locations) are planning to move into a unified multi-service facility in the nearby suburb of Palatine. This new joint office and warehouse space is under construction. Meanwhile, AIT Truckload Solutions will continue to serve customers out of their current location at 55 W. Monroe St. in Chicago.
Conveniently located near the intersection of Interstate 290 and the Elgin-O’Hare Expressway, AIT’s new global headquarters is easily accessible from O’Hare International Airport:
|
AIT Worldwide Logistics |
|
2 Pierce Place, Suite 2100 |
|
Itasca, IL 60143 |
|
Tel: +1 (630) 766-8300 |
Learn more about 2 Pierce Place at twopierceplace.com.
About AIT Worldwide Logistics
AIT Worldwide Logistics is a global freight forwarder that helps companies grow by expanding access to markets all over the world where they can sell and/or procure their raw materials, components and finished goods. For more than 40 years, the Chicago-based supply chain solutions leader has relied on a consultative approach to build a global network and trusted partnerships in nearly every industry, including aerospace, automotive, consumer retail, food, government, healthcare, high-tech, industrial and life sciences. Backed by scalable, user-friendly technology, AIT’s flexible business model customizes door-to-door deliveries via sea, air, ground and rail — on time and on budget. With expert teammates staffing more than 100 worldwide locations in Asia, Europe and North America, AIT’s full-service options also include customs clearance, warehouse management and white glove services. Learn more at www.aitworldwide.com.
Our Mission
At AIT, we vigorously seek opportunities to earn our customers’ trust by delivering exceptional worldwide logistics solutions while passionately valuing our co-workers, partners and communities.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230814443050/en/
Contact information
Matt Sanders
Public Relations Manager
+1 (630) 766-8300
msanders@aitworldwide.com
AIT Worldwide Logistics, Inc.
Corporate Headquarters
701 N. Rohlwing Road
Itasca, IL 60143
800-669-4AIT (4248)
www.aitworldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 11:11:00 EEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 09:00:00 EEST | Press release
Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521069859/en/ Boomi Named One of The Sunday Times Best Places to Work 2026 Boomi's results speak to a workplace culture that goes well beyond industry norms. The company achieved an average employee happiness score of 86%, rated Excellent, with consistent scores across all six dimensions of WorkL's framework. Most strikingly, Boomi's flight risk, the proportion of employees who may be considering leaving, stood at just 3%, against a technology se
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 08:09:00 EEST | Press release
LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through centers in Romania and Portugal. This would create a more diversified portfolio for LTM – expanding its scale in Europe and Australia, enhancing its position in regulated and high-growth verticals through marquee customer relationships. The deal would augment LTM’s global AI-centric capabilities with local domain and near-shore expertise crucial for delivering digital an
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 08:00:00 EEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
